Skip to main content

Want a detailed portfolio tracker?

Performance analysis of MiNK Therapeutics (INKT)

Annual Return

Over the past 3 years, INKT has had an average annual return of -15.44%, underperforming the benchmark SPY, which returned +19.63% annual.

Since Oct 15, 2021, INKT has had an average annual return of -39.34%, underperforming the benchmark SPY, which returned +12.99% annual.

202620252024202320222021
-0.65%+59.90%-34.87%-58.99%-41.49%-62.83%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+5.71%-7.03%-3.83%+15.83%+0%-4.23%-5.24%-0.65%
2025+31.33%-2.23%-3.49%-13.75%-5.64%+5.12%+105.03%-6.02%-1.68%+0.26%-25.13%+6.05%+59.90%
2024-19.17%+6.52%-1.43%+8.98%-2.06%-2.10%-1.01%-13.79%-7.41%-4.80%+2.69%-4.91%-34.87%
2023-12.41%-11.18%-6.68%-5.51%-1.68%+19.29%-10.97%-22.46%-24.09%-7.31%+2.94%+1.94%-58.99%
2022-26.23%-9.74%-24.24%-0.43%-30.80%-9.06%-7.06%+100.73%-19.80%+3.36%+21.52%-1.49%-41.49%
2021+49.08%-35.16%-61.55%-62.83%

Drawdown analysis of MiNK Therapeutics (INKT)

The maximum drawdown for the INKT was -97.69%, occurring on Dec 18, 2024. This drawdown has not yet recovered.

The current INKT drawdown is -94.47%.

Since Oct 15, 2021 INKT has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-97.69%Nov 11, 2021779Dec 18, 2024OngoingOngoingOngoing
-12.71%Nov 2, 20213Nov 5, 20214Nov 11, 20217
-4.77%Oct 21, 20212Oct 25, 20212Oct 27, 20214
-2.50%Oct 15, 20211Oct 18, 20211Oct 19, 20212